Page last updated: 2024-11-02

pantoprazole and Pyloric Stenosis

pantoprazole has been researched along with Pyloric Stenosis in 2 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Pyloric Stenosis: Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krogulska, A1
Grzelak-Czachorowska, K1
Daniluk-Matraś, I1
Kuczyńska, R1
Szaflarska-Poplawska, A1
Sennaroglu, E1
Karakan, S1
Kayatas, M1
Akdur, S1
Genc, H1
Karakan, T1
Ucler, R1
Ozisler, C1
Urun, Y1

Other Studies

2 other studies available for pantoprazole and Pyloric Stenosis

ArticleYear
Recurrent Nausea and Vomiting in a Teenager - A Rare Disease with Common Symptoms.
    Klinische Padiatrie, 2019, Volume: 231, Issue:1

    Topics: Adolescent; Anti-Ulcer Agents; Down Syndrome; Female; Gastric Outlet Obstruction; Gastritis; Gastros

2019
Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Edema; Follow-Up

2006